These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 33330310)

  • 1. Code-Sharing in Cost-of-Illness Calculations: An Application to Antibiotic-Resistant Bloodstream Infections.
    Naylor NR; Yamashita K; Iwami M; Kunisawa S; Mizuno S; Castro-Sánchez E; Imanaka Y; Ahmad R; Holmes A
    Front Public Health; 2020; 8():562427. PubMed ID: 33330310
    [No Abstract]   [Full Text] [Related]  

  • 2. Disease burden of bloodstream infections caused by antimicrobial-resistant bacteria: A population-level study, Japan, 2015-2018.
    Tsuzuki S; Matsunaga N; Yahara K; Shibayama K; Sugai M; Ohmagari N
    Int J Infect Dis; 2021 Jul; 108():119-124. PubMed ID: 33992765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are there differences in hospital cost between patients with nosocomial methicillin-resistant Staphylococcus aureus bloodstream infection and those with methicillin-susceptible S. aureus bloodstream infection?
    Ben-David D; Novikov I; Mermel LA
    Infect Control Hosp Epidemiol; 2009 May; 30(5):453-60. PubMed ID: 19344266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The health and cost burden of antibiotic resistant and susceptible Escherichia coli bacteraemia in the English hospital setting: A national retrospective cohort study.
    Naylor NR; Pouwels KB; Hope R; Green N; Henderson KL; Knight GM; Atun R; Robotham JV; Deeny SR
    PLoS One; 2019; 14(9):e0221944. PubMed ID: 31504046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The health and economic burden of bloodstream infections caused by antimicrobial-susceptible and non-susceptible Enterobacteriaceae and Staphylococcus aureus in European hospitals, 2010 and 2011: a multicentre retrospective cohort study.
    Stewardson AJ; Allignol A; Beyersmann J; Graves N; Schumacher M; Meyer R; Tacconelli E; De Angelis G; Farina C; Pezzoli F; Bertrand X; Gbaguidi-Haore H; Edgeworth J; Tosas O; Martinez JA; Ayala-Blanco MP; Pan A; Zoncada A; Marwick CA; Nathwani D; Seifert H; Hos N; Hagel S; Pletz M; Harbarth S;
    Euro Surveill; 2016 Aug; 21(33):. PubMed ID: 27562950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing methods to estimate incremental inpatient costs and length of stay due to methicillin-resistant Staphylococcus aureus in Alberta, Canada.
    Kirwin E; Varughese M; Waldner D; Simmonds K; Joffe AM; Smith S
    BMC Health Serv Res; 2019 Oct; 19(1):743. PubMed ID: 31651305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using the best available data to estimate the cost of antimicrobial resistance: a systematic review.
    Wozniak TM; Barnsbee L; Lee XJ; Pacella RE
    Antimicrob Resist Infect Control; 2019; 8():26. PubMed ID: 30733860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating the disease burden of methicillin-resistant Staphylococcus aureus in Japan: Retrospective database study of Japanese hospitals.
    Uematsu H; Yamashita K; Kunisawa S; Fushimi K; Imanaka Y
    PLoS One; 2017; 12(6):e0179767. PubMed ID: 28654675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Excess mortality and prolongation of stay due to bloodstream infections caused by multiresistant pathogens in Germany].
    Gastmeier P; Schwab F; Meyer E; Geffers C
    Dtsch Med Wochenschr; 2012 Aug; 137(34-35):1689-92. PubMed ID: 22893048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk Factors, Length of Stay and In-Hospital Mortality of Methicillin-Resistant Staphylococcus aureus Infections: A Case-Control Study.
    Rodrigues R; Passadouro R; Gomes O; Castro R
    Acta Med Port; 2020 Mar; 33(3):174-182. PubMed ID: 32130096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of bloodstream infections caused by methicillin-resistant Staphylococcus aureus at a tertiary care hospital in New York.
    Yasmin M; El Hage H; Obeid R; El Haddad H; Zaarour M; Khalil A
    Am J Infect Control; 2016 Jan; 44(1):41-6. PubMed ID: 26412481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CATheter Infections in CHildren (CATCH): a randomised controlled trial and economic evaluation comparing impregnated and standard central venous catheters in children.
    Harron K; Mok Q; Dwan K; Ridyard CH; Moitt T; Millar M; Ramnarayan P; Tibby SM; Muller-Pebody B; Hughes DA; Gamble C; Gilbert RE
    Health Technol Assess; 2016 Mar; 20(18):vii-xxviii, 1-219. PubMed ID: 26935961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The economic burden of methicillin-resistant Staphylococcus aureus in community-onset pneumonia inpatients.
    Uematsu H; Yamashita K; Kunisawa S; Fushimi K; Imanaka Y
    Am J Infect Control; 2016 Dec; 44(12):1628-1633. PubMed ID: 27475333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Economic burden of methicillin-resistant Staphylococcus aureus bacteremia in critical care patients in hospitals in Bogotá].
    Barrero LI; Castillo JS; Leal AL; Sánchez R; Cortés JA; Alvarez CA; González AL
    Biomedica; 2014; 34(3):345-53. PubMed ID: 25504122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of national strategies to reduce meticillin-resistant Staphylococcus aureus infections in Japan and England.
    Mizuno S; Iwami M; Kunisawa S; Naylor N; Yamashita K; Kyratsis Y; Meads G; Otter JA; Holmes AH; Imanaka Y; Ahmad R
    J Hosp Infect; 2018 Nov; 100(3):280-298. PubMed ID: 30369423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of methicillin-resistant Staphylococcus aureus in Japan.
    Uematsu H; Yamashita K; Mizuno S; Kunisawa S; Shibayama K; Imanaka Y
    Am J Infect Control; 2018 Oct; 46(10):1142-1147. PubMed ID: 29784441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective Antimicrobial Stewardship Strategies for Cost-effective Utilization of Telavancin for the Treatment of Patients With Hospital-acquired Bacterial Pneumonia Caused by Staphylococcus aureus.
    McKinnell JA; Corman S; Patel D; Leung GH; Gordon LM; Lodise TP
    Clin Ther; 2018 Mar; 40(3):406-414.e2. PubMed ID: 29454592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. National trend of blood-stream infection attributable deaths caused by Staphylococcus aureus and Escherichia coli in Japan.
    Tsuzuki S; Matsunaga N; Yahara K; Gu Y; Hayakawa K; Hirabayashi A; Kajihara T; Sugai M; Shibayama K; Ohmagari N
    J Infect Chemother; 2020 Apr; 26(4):367-371. PubMed ID: 31801696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial resistance trends in bloodstream infections at a large teaching hospital in China: a 20-year surveillance study (1998-2017).
    Tian L; Zhang Z; Sun Z
    Antimicrob Resist Infect Control; 2019; 8():86. PubMed ID: 31161033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost of bacteraemia caused by methicillin-resistant vs. methicillin-susceptible Staphylococcus aureus in Spain: a retrospective cohort study.
    Rubio-Terrés C; Garau J; Grau S; Martinez-Martinez L;
    Clin Microbiol Infect; 2010 Jun; 16(6):722-8. PubMed ID: 19712112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.